(MedPage Today) – Orlando – Adalimumab (Humira) was more effective than conventional immunosuppressive drugs in reducing or eliminating the need for corticosteroid use in patients with noninfectious uveitis, according to data from the ADVISE trial…
Adalimumab is the best conventional steroid-sparing treatment in uveitis